Institutional shares held 12.3 Million
813K calls
91.1K puts
Total value of holdings $50.2M
$3.31M calls
$370K puts
Market Cap $176M
43,334,900 Shares Out.
Institutional ownership 28.45%
# of Institutions 90


Latest Institutional Activity in CRDF

Top Purchases

Q3 2024
Renaissance Technologies LLC Shares Held: 602K ($2.45M)
Q3 2024
Nuveen Asset Management, LLC Shares Held: 338K ($1.37M)
Q3 2024
Northern Trust Corp Shares Held: 310K ($1.26M)
Q3 2024
Gsa Capital Partners LLP Shares Held: 187K ($760K)
Q3 2024
Two Sigma Advisers, LP Shares Held: 331K ($1.35M)

Top Sells

Q3 2024
Assenagon Asset Management S.A. Shares Held: 271K ($1.1M)
Q3 2024
Marshall Wace, LLP Shares Held: 143K ($582K)
Q3 2024
Millennium Management LLC Shares Held: 153K ($621K)
Q3 2024
Jump Financial, LLC Shares Held: 0 ($0)
Q3 2024
Goldman Sachs Group Inc Shares Held: 94K ($383K)

About CRDF

Cardiff Oncology, Inc., a clinical-stage oncology company, develops medicine treatment for cancer patients in California. Its lead drug candidate is onvansertib, an oral selective Polo-like Kinase 1 Inhibitor for anti-cancer therapeutics; CY140, an inhibitor of PLK1, PLK2, and PLK3 that is in phase 1/2 studies in solid tumors and leukemias; metastatic colorectal cancer that is in clinical trials; and TROV-054 is a Phase 1b/2 for FOLFIRI and bevacizumab. The company's TROV-053 is also in Phase II clinical trial in combination with Zytiga for metastatic castration-resistant prostate cancer. The company primarily serves pharmaceutical manufacturers. The company was formerly known as Trovagene, Inc. and changed its name to Cardiff Oncology, Inc. in May 2012. Cardiff Oncology, Inc. was incorporated in 1999 and is headquartered in San Diego, California.


Insider Transactions at CRDF

Insider Transaction List

View all
Date Insider Transaction Ownership Type Shares Traded Value / Price
View All Transactions

Last 12 Months Summary

Buy / Acquisition
379K Shares
From 3 Insiders
Open market or private purchase 379K shares
Sell / Disposition
0 Shares
From 0 Insiders

Track Institutional and Insider Activities on CRDF

Follow Cardiff Oncology, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CRDF shares.

Notify only if

Insider Trading

Get notified when an Cardiff Oncology, Inc. insider buys or sells CRDF shares.

Notify only if

News

Receive news related to Cardiff Oncology, Inc.

Track Activities on CRDF